alpha 2-plasmin inhibitor levels in relation to modes of urokinase administration.
D004305:Dose-Response Relationship, Drug; D010450:Endopeptidases / Q000008:administration & dosage*; D005341:Fibrinolysin; D006801:Humans; D007263:Infusions, Parenteral; D013997:Time Factors; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage*; D000979:alpha-2-Antiplasmin
D000979:alpha-2-Antiplasmin; D010450:Endopeptidases; D005341:Fibrinolysin; D014568:Urokinase-Type Plasminogen Activator